The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
(2011) · Hepatogastroenterology · doi:10.5754/hge11125 · Cited by 2,450
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Self-citationGhiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
Self-citationImai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Self-citationREGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Davies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Herberman, R. B., Nunn, M. E., Holden, H. T., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160205 · Cited by 885
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
Moretta, L., & Moretta, A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600019 · Cited by 615
Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A., & Martin, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601335103 · Cited by 597
Giebel, S. (2003) · Blood · doi:10.1182/blood-2003-01-0091 · Cited by 549
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
André, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.-H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2126 · Cited by 496
Self-citationIdentification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Walzer, T., Bléry, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., André, P., Gauthier, L., Daniel, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609692104 · Cited by 476
α-Type-1 Polarized Dendritic Cells
Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M., Storkus, W. J., & Kalinski, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1261 · Cited by 470
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 469
Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., & Moretta, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403744101 · Cited by 455
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A., & López-Botet, M. (2006) · Blood · doi:10.1182/blood-2005-09-3682 · Cited by 449
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L., & Yokoyama, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050588297 · Cited by 424
Killer immunoglobulin-like receptors
Moretta, L., & Moretta, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.010 · Cited by 409
A novel dendritic cell subset involved in tumor immunosurveillance
Taieb, J., Chaput, N., Ménard, C., Apetoh, L., Ullrich, E., Bonmort, M., Péquignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1356 · Cited by 405
Self-citationIshikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T., Nakayama, T., Taniguchi, M., & Fujisawa, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1453 · Cited by 403
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
Chan, C. W., Crafton, E., Fan, H.-N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1352 · Cited by 399
Fauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., & Costello, R. T. (2007) · Blood · doi:10.1182/blood-2005-08-027979 · Cited by 380
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
Davies, S. M., Ruggieri, L., DeFor, T., Wagner, J. E., Weisdorf, D. J., Miller, J. S., Velardi, A., & Blazar, B. R. (2002) · Blood · doi:10.1182/blood-2002-04-1197 · Cited by 368
Nature's TRAIL—On a Path to Cancer Immunotherapy
Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R. M., & Yagita, H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00502-2 · Cited by 366
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
Bukowski, R. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1198::aid-cncr3>3.0.co;2-h · Cited by 325
Natural killer cells in human health and disease
Orange, J. S., & Ballas, Z. K. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.011 · Cited by 318
Mortier, E., Quéméner, A., Vusio, P., Lorenzen, I., Boublik, Y., Grötzinger, J., Plet, A., & Jacques, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508624200 · Cited by 308
Borg, C., Terme, M., Taïeb, J., Ménard, C., Flament, C., Robert, C., Maruyama, K., Wakasugi, H., Angevin, E., Thielemans, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21102 · Cited by 302
α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles
Kaer, L. V. (2005) · Nature Reviews Immunology · doi:10.1038/nri1531 · Cited by 299
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290
Miller, J. S., Cooley, S., Parham, P., Farag, S. S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E. A., Haagenson, M., Horowitz, M. M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065383 · Cited by 288
Gollob, J., Mier, J. W., Veenstra, K. G., McDermott, D. F., Clancy, D., Clancy, M., & Atkins, M. B. (2000) · PubMed · Cited by 285
Ghiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
Self-citationPassweg, J. R., Tichelli, A., Meyer-Monard, S., Heim, D., Stern, M., Kühne, T., Favre, G., & Gratwohl, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403524 · Cited by 270
Chaput, N., Schartz, N. E. C., André, F., Taïeb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2137 · Cited by 266
Self-citationThe Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense
Bashirova, A. A., Martin, M. P., McVicar, D. W., & Carrington, M. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115726 · Cited by 265
Uherek, C., Tonn, T., Uherek, B., Becker, S., Schnierle, B., Klingemann, H.-G., & Wels, W. (2002) · Blood · doi:10.1182/blood.v100.4.1265.h81602001265_1265_1273 · Cited by 262
Burns, L. J., Weisdorf, D. J., DeFor, T. E., Vesole, D. H., Repka, T. L., Blazar, B. R., Burger, S. R., Panoskaltsis-Mortari, A., Keever-Taylor, C. A., Zhang, M.-J., et al. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704086 · Cited by 252
Ligands for natural killer cell receptors: redundancy or specificity
Cerwenka, A., & Lanier, L. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810113.x · Cited by 248
Functional subsets of mouse natural killer cells
Hayakawa, Y., Huntington, N. D., Nutt, S. L., & Smyth, M. J. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00454.x · Cited by 244
Farag, S. S., Bacigalupo, A., Eapen, M., Hurley, C., Dupont, B., Caligiuri, M. A., Boudreau, C., Nelson, G., Oudshoorn, M., van Rood, J., et al. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.05.007 · Cited by 243
Motohashi, S., Ishikawa, A., Ishikawa, E., Otsuji, M., Iizasa, T., Hanaoka, H., Shimizu, N., Horiguchi, S., Okamoto, Y., Fujii, S.-I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0114 · Cited by 239
Mazzaferro, V., Coppa, J. C., Carrabba, M. G., Rivoltini, L., Schiavo, M., Regalia, E., Mariani, L., Camerini, T., Marchianò, A. V., Andreola, S. A., et al. (2003) · PubMed · Cited by 239
Carrington, M., Wang, S., Martin, M. P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A. C., Kurman, R., Mortel, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042158 · Cited by 231
Human natural killer cell deficiencies
Orange, J. S. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3280106b65 · Cited by 229
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
Albertsson, P. A., Basse, P. H., Hokland, M., Goldfarb, R. H., Nagelkerke, J. F., Nannmark, U., & Kuppen, P. J. K. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.007 · Cited by 226
NK cells are essential for effective BCG immunotherapy
Brandau, S., Riemensberger, J., Jacobsen, M., Kemp, D., Zhao, W., Zhao, X., Jocham, D., Ratliff, T. L., & B�hle, A. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010601)92:5<697::aid-ijc1245>3.0.co;2-z · Cited by 212
Cooley, S., McCullar, V., Wangen, R., Bergemann, T. L., Spellman, S., Weisdorf, D. J., & Miller, J. S. (2005) · Blood · doi:10.1182/blood-2005-04-1644 · Cited by 207
Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines
Taieb, J., Chaput, N., Schartz, N., Roux, S., Novault, S., Ménard, C., Ghiringhelli, F., Terme, M., Carpentier, A. F., Darrasse-Jèse, G., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2722 · Cited by 200
Self-citationKammula, U. S., White, D. E., & Rosenberg, S. A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m · Cited by 200
Krieg, A. M., Efler, S. M., Wittpoth, M., Al Adhami, M. J., & Davis, H. L. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200411000-00006 · Cited by 184
Robertson, M. J., Cameron, C. A., Atkins, M. B., Gordon, M. S., Lotze, M. T., Sherman, M. L., & Ritz, J. (1999) · PubMed · Cited by 171
Robertson, M. J., Mier, J. W., Logan, T., Atkins, M., Koon, H., Koch, K. M., Kathman, S., Pandite, L. N., Oei, C., Kirby, L. C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0121 · Cited by 170
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells
Blasius, A. L., Barchet, W., Cella, M., & Colonna, M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070991 · Cited by 166
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma
Gluck, W. L., Hurst, D., Yuen, A., Levine, A. M., Dayton, M. A., Gockerman, J. P., Lucas, J., Denis-Mize, K., Tong, B., Navis, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1087-3 · Cited by 166
Davis, I. D., Skrumsager, B. K., Cebon, J., Nicholaou, T., Barlow, J. W., Moller, N. P. H., Skak, K., Lundsgaard, D., Frederiksen, K. S., Thygesen, P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0410 · Cited by 164
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Koh, C. Y., Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raziuddin, A., Murphy, W. J., & Bennett, M. (2001) · Blood · doi:10.1182/blood.v97.10.3132 · Cited by 160
Dendritic cell derived-exosomes: biology and clinical implementations
Chaput, N., Flament, C., Viaud, S., Taïeb, J., Roux, S., Spatz, A., André, F., Pecq, J. L., Boussac, M., Garin, J., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206094 · Cited by 160
Self-citationHayashi, T., Imai, K., Morishita, Y., Hayashi, I., Kusunoki, Y., & Nakachi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2776 · Cited by 159
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells
Vosshenrich, C. A. J., Lesjean‐Pottier, S., Hasan, M., Goff, O. R.-L., Corcuff, E., Mandelboim, O., & Santo, J. P. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071451 · Cited by 157
Link, B. K., Ballas, Z. K., Weisdorf, D. J., Wooldridge, J. E., Bossler, A., Shannon, M., Rasmussen, W. L., Krieg, A. Μ., & Weiner, G. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211304.60126.8f · Cited by 153
Gollob, J., Veenstra, K. G., Parker, R. A., Mier, J. W., McDermott, D. F., Clancy, D., Tutin, L., Koon, H. B., & Atkins, M. B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.119 · Cited by 148
Pilla, L., Patuzzo, R., Rivoltini, L., Maio, M., Pennacchioli, E., Lamaj, E., Maurichi, A., Massarut, S., Marchianò, A. V., Santantonio, C., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0084-8 · Cited by 137
Sivori, S., Parolini, S., Marcenaro, E., Castriconi, R., Pende, D., Millo, R., & Moretta, A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00221-6 · Cited by 132
Caminschi, I., Ahmet, F., Heger, K., Brady, J., Nutt, S. L., Vremec, D., Pietersz, S., Lahoud, M. H., Schofield, L., Hansen, D. S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071351 · Cited by 121
Parihar, R., Nadella, P. C., Lewis, A., Jensen, R. R., Hoff, C. D., Dierksheide, J. E., VanBuskirk, A. M., MAGRO, C. M. J., Young, D. C., Shapiro, C. L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0265 · Cited by 121
Shahied, L., Tang, Y., Alpaugh, R. K., Somer, R. A., Greenspon, D., & Weiner, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407888200 · Cited by 120
Chang, C., Campoli, M. R., & Ferrone, S. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)93006-6 · Cited by 117
McHutchison, J. G., Bacon, B. R., Gordon, S. C., Lawitz, E., Shiffman, M., Afdhal, N. H., Jacobson, I. M., Muir, A. J., Al-Adhami, M., Morris, M. L., et al. (2007) · Hepatology · doi:10.1002/hep.21773 · Cited by 114
Daniel, D., Yang, B., Lawrence, D. A., Tótpál, K., Balter, I., Lee, W. P., Gogineni, A., Cole, M. J., Yee, S. F., Ross, S., et al. (2007) · Blood · doi:10.1182/blood-2007-02-076075 · Cited by 112
Natural killer cells and natural killer cell activity in chronic fatigue syndrome
Whiteside, T. L., & Friberg, D. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00155-7 · Cited by 111
Khan, K. D., Emmanouilides, C. E., Benson, D. M., Hurst, D., Garcia, P., Michelson, G. C., Milan, S., Ferketich, A. K., Piro, L. D., Leonard, J. P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1571 · Cited by 105
Li, Z., Lim, W. K., Mahesh, S. P., Liu, B., & Nussenblatt, R. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5187 · Cited by 102
Hartmann, F., Renner, C., Jung, W. E., Costa, L. M. D., Tembrink, S., Held, G., Sek, A., König, J., Bauer, S., Kloft, M., et al. (2001) · PubMed · Cited by 99
Use of natural killer cells in hematopoetic stem cell transplantation
Passweg, J. R., Stern, M., Koehl, U., Uharek, L., & Tichelli, A. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704810 · Cited by 84
Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma
Vetter, C. S., Lieb, W., Bröcker, E.-B., & Becker, J. C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602123 · Cited by 77
Natural killer cell-based immunotherapeutic strategies
Klingemann, H.-G. (2005) · Cytotherapy · doi:10.1016/s1465-3249(05)70785-4 · Cited by 73
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity
Osada, T., Clay, T. D., Hobeika, A. C., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0089-3 · Cited by 70
Kim, M. H., Kitson, R. P., Albertsson, P., Nannmark, U., Basse, P. H., Kuppen, P. J. K., Hokland, M., & Goldfarb, R. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5883 · Cited by 68
Lotze, M. T., & Rosenberg, S. A. (1986) · Immunobiology · doi:10.1016/s0171-2985(86)80122-x · Cited by 66
Rodella, L. F., Zamai, L., Rezzani, R., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03055.x · Cited by 57
Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease1
Liu, R.-L., van Kaer, L., la Cava, A., Price, M., Campagnolo, D., Collins, M., Young, D., Vollmer, T., & Shi, F.-D. (2006) · Journal of Immunology · doi:10.4049/jimmunol.176.9.5247 · Cited by 56
Berdeja, J. G., Hess, A. D., Lucas, D. M., O’Donnell, P. V., Ambinder, R. F., Diehl, L. F., Carter-Brookins, D., Newton, S., & Flinn, I. W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1860 · Cited by 56
Pilla, L., Squarcina, P., Coppa, J. C., Mazzaferro, V., Huber, V., Pende, D., Maccalli, C., Sovena, G., Mariani, L., Castelli, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3493 · Cited by 46
Chen, W., Chan, A. S. H., Dawson, A. J., Liang, X., Blazar, B. R., & Miller, J. S. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.08.004 · Cited by 38
Bonmort, M., Ullrich, E., Mignot, G., Jacobs, B., Chaput, N., & Zitvogel, L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.014 · Cited by 29
Self-citationRenner, C., Hartmann, F., Jung, W. E., Deisting, C., Juwana, M., & Pfreundschuh, M. G. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050617 · Cited by 23
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationTargeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Fujisaki, H., Kakuda, H., Shimasaki, N., Imai, C., Ma, J., Lockey, T., Eldridge, P., Leung, W. H., & Campana, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3712 · Cited by 595
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Hudak, J. E., Canham, S. M., & Bertozzi, C. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1388 · Cited by 485
Parkhurst, M. R., Riley, J. P., Dudley, M. E., & Rosenberg, S. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1347 · Cited by 475
Metadata
- Authors
- Terme, M., Ullrich, E., Delahaye, N. F., Chaput, N., & Zitvogel, L.
- Venue
- Nature Immunology
- Published
- 2008-04-18
- Volume
- 9
- Issue
- 5
- Pages
- 486-494
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2019804037
- Cited by
- 289
- References
- 113
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.